frtzblk
43 minutes ago
Time is money and time is short for all the promises for Leronlimab.
Reading messages, many new trials have been started using Leronlimab for 5 or ten diseases to fight, This is an ambiscion, that is difficult to accomplish in 2024
I am not an expert in in this business, but common sen